|
|
|
市場調査レポート
英国における44 NA試験のための分子診断市場分析
Assessment of the Molecular Diagnostic Market for 44 NA Tests in UK
|
Abstract
This is the most comprehensive European market report on the emergent field of
molecular diagnostics from the end user perspective. Hospital and private
laboratories have been surveyed to collect information on NA tests performed,
test volumes and used platforms and reagents. For data reliability and
accurate projections at segment level a 3 step methodology has been
applied:
- Step 1: Identification of the total number of laboratories by
secondary research and short telephone interviews with 561 hospitals to verify
existence of internal laboratories.
- Step 2: 355 laboratories in UK were classified for NAT activity
and overall NA test volume.
- Step 3: 36 laboratories provided data on NA test volume, kits,
platforms and trends. A list of 44 NA tests have been provided to the labs
for structured data entry. All data has been analysed and projected at total
market level. The report discusses tests and technologies that are currently
available and wishes from the end user perspectives. The report covers key
platforms of molecular diagnostics, including Polymerase Chain Reaction (PCR),
Real Time PCR (RT-PCR), TMA, LCR, NASBA, SDA, HCA, bDNA.
Table of Contents
- Total number of clinical diagnostic labs by lab type: small, medium and
large hospitals, non hospital (private) labs
- Number of clinical diagnostic NA labs by lab type: small, medium and large
hospitals, non hospital (private) labs, and by NA test volume: >/< 20 NA
tests per day
- # of lab performing test by test types (Adenovirus, BK, C. Diff, CF, CMV,
CMV Viral, CT, CT/NG, EBV, EBV Viral, Enterovirus, Factor II, Factor V Leiden,
Fragile X, GAS, GBS, HBV qual, HBV resistance, HBV Viral Load, HCV Genotyping,
HCV qual, HCV Viral Load, Her2Neu, HIV Genotyping, HIV qual, HIV Viral Load,
HLA Typing, HPV, HPV Genotyping, HSV 1, HSV 2, Human Metapneumovirus,
Influenza A, B, MAC (formerly MAI), MRSA, MSSA, MTB, MTD (Tuberculosis), NG,
Parainfluenza 1,2,3, RSV, Staphylococcus aureus, VRE, VZV, Warfarin
sensitivity (CYP2C9, VKOR1))
- Total # of test/results per test type & growth rate (Adenovirus, BK, C.
Diff, CF, CMV, CMV Viral, CT, CT/NG, EBV, EBV Viral, Enterovirus, Factor II,
Factor V Leiden, Fragile X, GAS, GBS, HBV qual, HBV resistance, HBV Viral
Load, HCV Genotyping, HCV qual, HCV Viral Load, Her2Neu, HIV Genotyping, HIV
qual, HIV Viral Load, HLA Typing, HPV, HPV Genotyping, HSV 1, HSV 2, Human
Metapneumovirus, Influenza A, B, MAC (formerly MAI), MRSA, MSSA, MTB, MTD
(Tuberculosis), NG, Parainfluenza 1,2,3, RSV, Staphylococcus aureus, VRE, VZV,
Warfarin sensitivity (CYP2C9, VKOR1))
- Market share: # of tests/results by supplier (Roche Diagnostics,
Innogenetics, Abbott, Bio-Rad, bioMerieux, Stratagene, Applied Biosystems,
Qiagen, Siemens, Cepheid, Digene)
- Installed base of analyzers
- Trends
|
 |
